EULAR 2021 Janssen-Sponsored symposium: “The launching pad: exploring the potential of the IL-23 pathway in psoriatic arthritis.”

Bonus Episode

EULAR 2021 Janssen-Sponsored symposium: “The launching pad: exploring the potential of the IL-23 pathway in psoriatic arthritis.”

Discussing presentations from experts Georg Schett, Freidrich-Alexander University, Erlangen-Nürnberg, Germany; Stefan Siebert, University of Glasgow, UK; and Christopher Griffiths, University of Manchester, UK, the first podcast reviews evidence exploring the potential of the IL-23 pathway in PsA. The discussions highlight both the role highlight both the role of the IL-23 pathway in the pathogenesis of PsA and the potential IL-23 inhibitors hold for improving PsA outcomes.

Spotify | Apple | Acast | Download MP3 (mp 11:35 mins)

This podcast is supported by Janssen Pharmaceutical Companies of Johnson & Johnson. The views expressed in this podcast are those of the individual speaker and do not necessarily reflect the views of Janssen Pharmaceutical Companies of Johnson & Johnson.